HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
177278.0,245895,2145-01-15 06:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Resp were unlabored, no accessory muscle use. Crackles at bases
   b/l L>R.
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   PT / PTT / INR:12.6/29.7/1.1,
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, Metoprolol
   Tartrate 37.5 mg Q6H
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemtry
   .
   #. HTN:
   - Continue metoprolol
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: will stay in CCU for now
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Resp were unlabored, no accessory muscle use. Crackles at bases
   b/l L>R.
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   PT / PTT / INR:12.6/29.7/1.1,
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, Metoprolol
   Tartrate 37.5 mg Q6H
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemtry
   .
   #. HTN:
   - Continue metoprolol
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: will stay in CCU for now<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD) who was transferred from the operating room (OSH) to the CCU due to unstable angina.

The patient's current condition is stable, with no chest pain overnight since admission. She is receiving medical management for her CAD, including nitroglycerin, heparin, clopidogrel, and aspirin. However, heparin was discontinued last night due to active gastrointestinal bleeding (GIB).

The patient has a history of GIB, with a hemoglobin (Hb) level of 34 on admission, which dropped to 28 on transfer and 22.7 last night. She has been transfused with 2 units of packed red blood cells (pRBCs) overnight, resulting in an increase in her Hb level to 27.1. A computed tomography (CT) scan of the abdomen and pelvis ruled out retroperitoneal bleeding.

The patient's renal function is impaired, with a creatinine level of 1.6. She has multiple well-circumscribed bilateral renal lesions, which may represent simple cysts, and correlation with prior imaging or a renal ultrasound is warranted.

The patient has a history of peripheral vascular disease (PVD) and is at high risk for peripheral arterial disease. She is currently not receiving pentoxifylline due to her PVD.

The patient's electrolyte levels are within normal limits, with the exception of a slightly elevated potassium level. Her liver function tests (LFTs) are within normal limits.

The patient's respiratory status is stable, with a respiratory rate of 16 breaths per minute and an oxygen saturation of 98% on nasal cannula.

The patient's cardiovascular status is stable, with a heart rate of 73 beats per minute and a blood pressure of 153/64 mmHg.

The patient's neurological status is stable, with a Glasgow Coma Scale (GCS) score of 15.

The patient's gastrointestinal status is stable, with no evidence of bleeding or obstruction.

The patient's urinary status is stable, with a urinary output of 600 mL overnight.

The patient's laboratory results show:

* Hemoglobin: 27.1 g/dL
* Hematocrit: 22.7%
* Platelet count: 174 K/uL
* White blood cell count: 6.9 K/uL
* Creatinine: 1.6 mg/dL
* Blood urea nitrogen (BUN): 34 mg/dL
* Electrolyte levels: within normal limits

The patient's medications include:

* Nitroglycerin
* Heparin
* Clopidogrel
* Aspirin
* Metoprolol
* Atorvastatin
* Famotidine

The patient's plan includes:

* Continue medical management for CAD
* Continue heparin-free anticoagulation
* Monitor for signs of bleeding or bleeding complications
* Monitor for signs of renal dysfunction or worsening of renal function
* Consider coronary angiography or percutaneous coronary intervention (PCI) for CAD
* Consider renal ultrasound or other imaging studies to evaluate renal lesions
* Consider outpatient renal US to monitor renal function.

Potential medical complications that may arise include:

* Bleeding complications due to heparin-free anticoagulation
* Worsening of renal function or acute kidney injury (AKI)
* Development of cardiovascular complications, such as heart failure or arrhythmias
* Development of gastrointestinal complications, such as bleeding or obstruction
* Development of respiratory complications, such as pneumonia or acute respiratory distress syndrome (ARDS)
* Development of neurological complications, such as stroke or seizures
* Development of electrolyte imbalances or acid-base disorders."
177278.0,245895,2145-01-15 06:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   got 2u pRBC overnight, pt felt
100% better
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences. Pt feeling much better after getting blood
   transfusion.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: bibasilar crackles, improved after cough
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, plavix 75mg daily
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30, give another unit now
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 160s range in the AM on [**1-15**].
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: if patient continues to be asymptomatic, nitro gtt can be
   weaned down, and if patient is not going for high risk PCI today, can
   call out to floor today
   ------ Protected Section ------
   Attending
s Note: 09.00hrs
   Agree with Dr.[**First Name (STitle) 1050**]
s note.
   Reviewed data and examined Pt.
   Cardiac issues stable.Needs better BP control
   [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 6658**]
   Spent 45mins
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Name (NI) 6658**]
   on:[**2145-1-16**] 12:17 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   got 2u pRBC overnight, pt felt
100% better
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences. Pt feeling much better after getting blood
   transfusion.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: bibasilar crackles, improved after cough
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, plavix 75mg daily
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30, give another unit now
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 160s range in the AM on [**1-15**].
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: if patient continues to be asymptomatic, nitro gtt can be
   weaned down, and if patient is not going for high risk PCI today, can
   call out to floor today
   ------ Protected Section ------
   Attending
s Note: 09.00hrs
   Agree with Dr.[**First Name (STitle) 1050**]
s note.
   Reviewed data and examined Pt.
   Cardiac issues stable.Needs better BP control
   [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 6658**]
   Spent 45mins
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Name (NI) 6658**]
   on:[**2145-1-16**] 12:17 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD) who was transferred from another hospital with 98% left main disease. She has been experiencing unstable angina, which has been medically managed with nitroglycerin, heparin, clopidogrel, and aspirin. Due to her active gastrointestinal bleeding (GIB), heparin was discontinued, and she received 2 units of packed red blood cells (pRBC) overnight, which improved her hemoglobin (Hb) level from 22.7 to 27.1.

The patient's current condition is stable, with no chest pain or symptoms overnight. Her vital signs are stable, with a blood pressure (BP) of 153/64 mmHg, heart rate (HR) of 73 beats per minute (bpm), and respiratory rate (RR) of 16 inspirations per minute (ipm). Her oxygen saturation (SpO2) is 98% on nasal cannula oxygen.

The patient has multiple well-circumscribed bilateral renal lesions, which may represent simple cysts or require further evaluation with a renal ultrasound. She also has extensive atherosclerotic calcification and disease with associated luminal narrowing.

The patient's plan includes:

1. Continue nitroglycerin, aspirin, atorvastatin, and clopidogrel.
2. Increase metoprolol tartrate from 37.5 mg to 50 mg every 6 hours.
3. Start hydralazine 25-50 mg every 6 hours.
4. Transfuse 2 units of pRBC to achieve a hemoglobin level of 30.
5. Perform a transesophageal echocardiogram (TTE) today.
6. Consider high-risk PCI with TandemHeart assistance today or on Monday.
7. Continue to monitor for signs of lower gastrointestinal bleeding.

Potential medical complications:

1. Gastrointestinal bleeding: The patient has a history of GIB, and the risk of further bleeding is high. Close monitoring of her hemoglobin levels and stool output is necessary.
2. Renal insufficiency: The patient has chronic kidney disease (CKD) stage III-IV, and her creatinine level is 1.6 mg/dL. Close monitoring of her kidney function and avoidance of renal toxins are necessary.
3. Hypertension: The patient's blood pressure is high, and it needs to be controlled to prevent further complications.
4. Cardiac complications: The patient has a history of CAD and AS, and she is at high risk for cardiac complications, such as myocardial infarction or cardiac arrhythmias.
5. Respiratory complications: The patient has chronic obstructive pulmonary disease (COPD) and is at risk for respiratory complications, such as pneumonia or acute respiratory distress syndrome (ARDS).
6. Infection: The patient is at risk for infection due to her immunosuppressed state and the presence of central lines and catheters.
7. Bleeding complications: The patient has a history of bleeding complications, and the risk of further bleeding is high, especially with the use of anticoagulant medications.

Overall, the patient requires close monitoring and management of her multiple medical conditions to prevent further complications and ensure her safety and well-being."
177278.0,245895,2145-01-15 06:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   got 2u pRBC overnight, pt felt
100% better
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences. Pt feeling much better after getting blood
   transfusion.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: bibasilar crackles, improved after cough
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, plavix 75mg daily
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30, give another unit now
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 160s range in the AM on [**1-15**].
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: if patient continues to be asymptomatic, nitro gtt can be
   weaned down, and if patient is not going for high risk PCI today, can
   call out to floor today
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   got 2u pRBC overnight, pt felt
100% better
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences. Pt feeling much better after getting blood
   transfusion.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: bibasilar crackles, improved after cough
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, plavix 75mg daily
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30, give another unit now
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 160s range in the AM on [**1-15**].
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: if patient continues to be asymptomatic, nitro gtt can be
   weaned down, and if patient is not going for high risk PCI today, can
   call out to floor today<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD) who was transferred to the ICU from the operating room (OSH) with unstable angina. She has a high risk of PCI due to her 98% distal left main disease. She received 2 units of packed red blood cells (pRBC) overnight and her hemoglobin (Hct) improved from 22.7 to 27.1. She is currently receiving nitroglycerin, heparin, clopidogrel, and aspirin. She has a possible lower gastrointestinal bleed (GIB) and is being monitored for signs of bleeding.

Potential Medical Complications:

1. Hemorrhagic complications: The patient's GIB and decreased Hct may indicate a risk of hemorrhagic complications, such as bleeding into the digestive tract or retroperitoneal space.
2. Cardiac complications: The patient's CAD and AS may lead to cardiac complications, such as acute coronary syndrome, cardiogenic shock, or arrhythmias.
3. Renal complications: The patient's chronic kidney disease (CKD) stage III-IV and elevated creatinine levels may increase the risk of acute kidney injury (AKI) or worsening of CKD.
4. Respiratory complications: The patient's bibasilar crackles and possible lower GIB may indicate a risk of respiratory complications, such as pneumonia or acute respiratory distress syndrome (ARDS).
5. Neurological complications: The patient's atherosclerotic disease and possible lower GIB may increase the risk of neurological complications, such as stroke or transient ischemic attack (TIA).
6. Infection: The patient's GIB and possible lower GIB may increase the risk of infection, such as sepsis or bacteremia.
7. Gastrointestinal complications: The patient's GIB and possible lower GIB may lead to gastrointestinal complications, such as bowel obstruction or perforation.
8. Vascular complications: The patient's atherosclerotic disease and possible lower GIB may increase the risk of vascular complications, such as peripheral artery disease or venous thromboembolism (VTE).
9. Anemia: The patient's decreased Hct may lead to anemia, which may worsen her cardiovascular and respiratory status.
10. Medication-related complications: The patient's medications, such as clopidogrel and aspirin, may increase the risk of bleeding or gastrointestinal complications.

Recommendations:

1. Continue to monitor the patient's hemodynamic status, including blood pressure, heart rate, and central venous pressure.
2. Monitor the patient's renal function and adjust her medications accordingly.
3. Monitor the patient's gastrointestinal status, including bowel movements and abdominal pain.
4. Consider performing a renal ultrasound to evaluate the patient's renal lesions.
5. Consider performing a colonoscopy to evaluate the patient's lower gastrointestinal tract.
6. Continue to monitor the patient's neurological status and consider performing a head computed tomography (CT) scan if she experiences any neurological symptoms.
7. Consider adjusting the patient's medications to minimize the risk of bleeding and gastrointestinal complications.
8. Continue to monitor the patient's electrolyte levels and adjust her medications accordingly.
9. Consider performing a stress test to evaluate the patient's cardiac function.
10. Consider performing a echocardiogram to evaluate the patient's cardiac function and structure."
177278.0,245895,2145-01-15 06:50:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   got 2u pRBC overnight, pt felt
100% better
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences. Pt feeling much better after getting blood
   transfusion.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: bibasilar crackles
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, Metoprolol
   Tartrate 37.5 mg Q6H
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemtry
   .
   #. HTN:
   - Continue metoprolol
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: will stay in CCU for now
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 NASAL SWAB - At [**2145-1-14**] 09:17 PM
   Patient was chest pain free overnight since arriving at CCU
   got 2u pRBC overnight, pt felt
100% better
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-15**] 06:17 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.3
C (99.2
   Tcurrent: 36.5
C (97.7
   HR: 73 (64 - 79) bpm
   BP: 153/64(88) {111/44(61) - 153/95(108)} mmHg
   RR: 16 (11 - 21) insp/min
   SpO2: 98%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 67 Inch
           Total In:
                                                                    301 mL
                                                                    769 mL
   PO:
                                                                    120 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     93 mL
                                                                    171 mL
   Blood products:
                                                                     87 mL
                                                                    479 mL
   Total out:
                                                                      0 mL
                                                                    600 mL
   Urine:
   600 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    301 mL
                                                                    169 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 98%
   ABG: ///32/
   Physical Examination
   Gen: NAD. Oriented x3. Mood, affect appropriate. Speaking comfortably
   in full sentences. Pt feeling much better after getting blood
   transfusion.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of 8 cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: bibasilar crackles
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: No LE edema. R femoral bruits. Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   174 K/uL
   9.4 g/dL
   104 mg/dL
   1.6 mg/dL
   32 mEq/L
   4.1 mEq/L
   34 mg/dL
   100 mEq/L
   140 mEq/L
   27.1 %
   7.3 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
   WBC
   6.9
   7.3
   Hct
   22.7
   27.1
   Plt
   218
   174
   Cr
   1.5
   1.6
   Glucose
   237
   104
   Other labs:
   Ca++:9.1 mg/dL, Mg++:2.8 mg/dL, PO4:2.8 mg/dL
   CT abd/pelvis:
   1. No evidence of retroperitoneal hemorrhage.
   2. Multiple well-circumscribed bilateral renal lesions, some of which
   may
   represent simple cysts, though with some of slightly higher attenuation
   and
   correlation with prior imaging is recommended, and if no prior imaging
   is
   available, a renal ultrasound can be performed on a non-emergent basis
   for
   further evaluation.
   3. Extensive atherosclerotic calcification and disease with associated
   luminal narrowing that is incompletely assessed on this non-contrast
   imaging
   study.
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, Metoprolol
   Tartrate 37.5 mg Q6H
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemtry
   .
   #. HTN:
   - Continue metoprolol
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO famotidine
   ICU Care
   Nutrition:
   cardiac/heart healthy; currently npo in case pt is going for cath today
   Glycemic Control:  not on insulin, f/u HgbA1c
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: pneumoboots
   Stress ulcer:  PO famotidine
   VAP:  not indicated
   Comments:
   Communication:  Comments: [**First Name8 (NamePattern2) **] [**Known lastname **], [**Telephone/Fax (1) 12922**]; [**Numeric Identifier 12923**]  [**Doctor First Name 948**]
   ([**2145**]
   Code status: Full code, confirmed
   Disposition: will stay in CCU for now<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 83-year-old female with a history of aortic stenosis (AS), coronary artery disease (CAD), and stage III-IV chronic kidney disease (CKD). She was admitted to the intensive care unit (ICU) with unstable angina, and her condition has been managed with medical therapy.

The patient's current vital signs are:

* Temperature: 37.3C (99.2F)
* Heart rate: 73 beats per minute (bpm)
* Blood pressure: 153/64 mmHg
* Respiratory rate: 16 breaths per minute (inspiratory)
* Oxygen saturation: 98%

The patient's physical examination reveals:

* General: Alert and oriented, with a normal affect and mood
* Head, Eyes, Ears, Nose, and Throat (HEENT): Normal
* Cardiovascular (CV): Nondisplaced PMI, normal S1 and S2 sounds, 3/6 systolic murmur radiating to the carotids
* Chest: Bibasilar crackles
* Abdomen: Soft, non-tender, and non-distended
* Extremities: No lower extremity edema, warm, and well-perfused

Laboratory results show:

* White blood cell count (WBC): 6.9-7.3 x 10^9/L
* Hemoglobin (Hb): 22.7-27.1 g/dL
* Platelet count (Plt): 174-218 x 10^9/L
* Creatinine (Cr): 1.5-1.6 mg/dL
* Blood urea nitrogen (BUN): 32-34 mg/dL
* Glucose: 104-237 mg/dL

The patient has a history of gastrointestinal bleeding (GIB) and is at high risk for further bleeding. She has been receiving anticoagulation therapy, which was discontinued last night due to active GIB. The patient's hemoglobin level has improved from 22.7 to 27.1 g/dL after receiving 2 units of packed red blood cells (pRBC) overnight.

The patient has a history of aortic stenosis, coronary artery disease, and peripheral vascular disease (PVD). She is at high risk for PCI due to her 98% distal left main disease. The patient's unstable angina has been medically managed with nitroglycerin, heparin, clopidogrel, and aspirin.

The patient's plan includes:

* Continuing nitroglycerin, aspirin, atorvastatin, and metoprolol
* Transfusing pRBC to maintain a hemoglobin level of 30 g/dL
* Monitoring for signs of bleeding
* Discontinuing heparin due to active GIB
* Considering high-risk PCI with TandemHeart assistance
* Performing a renal ultrasound to evaluate the patient's bilateral renal lesions

Potential medical complications that may arise include:

* Further gastrointestinal bleeding
* Hemorrhagic shock
* Renal failure
* Cardiac complications due to high-risk PCI
* Peripheral vascular complications due to PVD
* Respiratory failure due to bibasilar crackles
* Infection due to prolonged ICU stay

It is essential to closely monitor the patient's condition and adjust her treatment plan accordingly to prevent or minimize these potential complications."
177278.0,245895,2145-01-16 07:56:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Gen: NAD. Oriented x3. Loquacious, speaking comfortably in full
   sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of [**5-24**] cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Clear to auscultation throughout
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: Trace L lower extremity edema, Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension.
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition: Cardiac diet
   Glycemic Control:  None
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SC Heparin
   Stress ulcer: Famotidine
   VAP:
   Comments:
   Communication:  Patient
   Code status: Full code
   Disposition: CCU for now, but ok for [**Hospital Ward Name 289**] 3
   ------ Protected Section ------
   Attending
s Note:
   Reviewed data and examined Pt.
   Much better.Awaiting extensive intervention
   Rx plan as outlined.
   [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 6658**]
   Spent 40mins on case
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Name (NI) 6658**]
   on:[**2145-1-16**] 12:21 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Gen: NAD. Oriented x3. Loquacious, speaking comfortably in full
   sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of [**5-24**] cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Clear to auscultation throughout
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: Trace L lower extremity edema, Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension.
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition: Cardiac diet
   Glycemic Control:  None
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SC Heparin
   Stress ulcer: Famotidine
   VAP:
   Comments:
   Communication:  Patient
   Code status: Full code
   Disposition: CCU for now, but ok for [**Hospital Ward Name 289**] 3
   ------ Protected Section ------
   Attending
s Note:
   Reviewed data and examined Pt.
   Much better.Awaiting extensive intervention
   Rx plan as outlined.
   [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 6658**]
   Spent 40mins on case
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Name (NI) 6658**]
   on:[**2145-1-16**] 12:21 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD) who was transferred from another hospital with unstable angina. She has undergone medical management with nitroglycerin, heparin, clopidogrel, and aspirin, and has received 2 units of packed red blood cells (pRBC) due to anemia. Her hemoglobin (Hb) level has increased from 22.7 to 27.1 after the transfusion.

The patient has been experiencing hypertension, with systolic blood pressure (SBP) in the 130s since increasing her antihypertensive regimen and discontinuing nitroglycerin. She has also been experiencing tachycardia, with a heart rate of 59 beats per minute (bpm).

The patient's laboratory results show elevated troponin-T levels, indicating possible cardiac injury. Her creatinine level is 1.6 mg/dL, indicating stage III-IV chronic kidney disease (CKD). Her electrolyte levels are within normal limits, except for a slightly elevated potassium level.

The patient's physical examination reveals a nondisplaced pericardial knock, a normal S1 and S2 heart sounds, and a 3/6 systolic murmur radiating to the carotids. Her abdominal examination is normal, with no evidence of ascites or organomegaly.

Assessment and Plan:

The patient's unstable angina has been medically managed, but she is at high risk for percutaneous coronary intervention (PCI) due to her 98% distal left main disease. She is also at high risk for bleeding due to her platelet count of 216,000/L and her international normalized ratio (INR) of 1.0.

The patient's hypertension has been controlled with an increased antihypertensive regimen, and her tachycardia has been managed with metoprolol tartrate. Her anemia has been managed with transfusion of pRBC.

The patient's CKD has been managed with monitoring of her creatinine level and avoidance of renal toxins. She has been advised to avoid renal toxins and to receive a renal ultrasound.

The patient's possible lower gastrointestinal (GI) bleed has been ruled out with a computed tomography (CT) scan of the abdomen and pelvis. She has been advised to receive daily complete blood counts (CBCs) and to continue taking famotidine.

Potential Medical Complications:

1. Cardiac complications: The patient's unstable angina and cardiac injury may lead to further cardiac complications, such as myocardial infarction, cardiac arrhythmias, or heart failure.
2. Bleeding complications: The patient's bleeding risk is high due to her platelet count and INR. She may experience bleeding complications, such as gastrointestinal bleeding, intracranial bleeding, or bleeding at the surgical site.
3. Renal complications: The patient's CKD may worsen due to her underlying kidney disease and her increased creatinine level. She may experience further kidney damage or require dialysis.
4. Infection complications: The patient's immune system may be compromised due to her underlying medical conditions, making her susceptible to infections, such as pneumonia, urinary tract infections, or wound infections.
5. Gastrointestinal complications: The patient's possible lower GI bleed has been ruled out, but she may still experience gastrointestinal complications, such as nausea, vomiting, or abdominal pain."
177278.0,245895,2145-01-16 07:56:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Gen: NAD. Oriented x3. Loquacious, speaking comfortably in full
   sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of [**5-24**] cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Clear to auscultation throughout
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: Trace L lower extremity edema, Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension.
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition: Cardiac diet
   Glycemic Control:  None
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SC Heparin
   Stress ulcer: Famotidine
   VAP:
   Comments:
   Communication:  Patient
   Code status: Full code
   Disposition: CCU for now, but ok for [**Hospital Ward Name 289**] 3
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Gen: NAD. Oriented x3. Loquacious, speaking comfortably in full
   sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of [**5-24**] cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Clear to auscultation throughout
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: Trace L lower extremity edema, Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension.
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition: Cardiac diet
   Glycemic Control:  None
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SC Heparin
   Stress ulcer: Famotidine
   VAP:
   Comments:
   Communication:  Patient
   Code status: Full code
   Disposition: CCU for now, but ok for [**Hospital Ward Name 289**] 3<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD). She was transferred from another hospital with 98% left main disease and was diagnosed with unstable angina. The patient is at high risk for percutaneous coronary intervention (PCI) due to her distal left main disease and has patent right internal mammary artery (RIMA)-right coronary artery (RCA) that provides collateral flow to her left anterior descending (LAD) artery.

The patient has been medically managed with nitroglycerin, heparin, clopidogrel, and aspirin, and has received 2 units of packed red blood cells (pRBC) on admission. Her hemoglobin (Hct) has been stable, ranging from 22.7 to 33.0%.

The patient has a history of gastrointestinal bleeding (GIB) and has been diagnosed with possible lower gastrointestinal bleeding (LGIB). She has been treated with 2u pRBC overnight, and her Hct has increased from 22.7 to 27.1. A computed tomography (CT) abdomen and pelvis ruled out rectal bleeding, and the patient's Hct is stable at 33.0%.

The patient has chronic kidney disease (CKD) stage III-IV, with a creatinine level of 1.6. She has multiple well-circumscribed bilateral renal lesions on CT abdomen and pelvis, and a renal ultrasound is recommended.

The patient has peripheral vascular disease (PVD) and is on hold Pentoxifylline 400mg TID. She also has gastroesophageal reflux disease (GERD) and is taking Tums and Famotidine.

The patient's vital signs are stable, with a temperature of 37.2C, heart rate of 59 beats per minute, blood pressure of 140/43 mmHg, respiratory rate of 17 breaths per minute, and oxygen saturation of 95%. Her physical examination is also stable, with no evidence of fluid overload or right-sided failure.

Based on the patient's condition, potential medical complications that may arise include:

1. Gastrointestinal bleeding: The patient has a history of GIB and is at risk for further bleeding, especially with her recent discontinuation of heparin.
2. Cardiac complications: The patient's unstable angina and CAD may lead to further cardiac complications, such as myocardial infarction or cardiac arrest.
3. Kidney disease progression: The patient's CKD stage III-IV may progress further, leading to end-stage renal disease (ESRD).
4. Peripheral vascular disease progression: The patient's PVD may progress further, leading to worsening symptoms and potential complications.
5. Infection: The patient's immunosuppressed state may make her more susceptible to infection, especially with her recent use of antibiotics.
6. Fluid overload: The patient's fluid management may lead to fluid overload, especially with her recent use of diuretics.
7. Hypertension: The patient's hypertension may worsen, leading to further cardiovascular complications.

In conclusion, the patient is at high risk for various medical complications, and close monitoring and management are necessary to prevent and treat these complications."
177278.0,245895,2145-01-16 07:56:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 70-year-old male admitted to the ICU with an unknown chief complaint. The patient has been transfused with 1 unit of blood and has received various medications, including lasix, hydralazine, and lopressor, to manage blood pressure and fluid overload. The patient's vital signs are stable, with a blood pressure in the 140s, heart rate of 59-81 bpm, and respiratory rate of 17-23 breaths per minute. The patient's oxygen saturation is 95% and is not requiring respiratory support.

The patient's laboratory results show a hemoglobin level of 30.3 g/dL, platelet count of 216 K/uL, and a white blood cell count of 6.9 K/uL. The patient's creatinine level is 1.6 mg/dL, and the troponin-T level is 0.28 ng/mL.

Potential Medical Complications:

1. Fluid overload: The patient has received 2,448 mL of fluids over the past 24 hours, which may lead to fluid overload and increased risk of cardiovascular complications.
2. Hypotension: The patient's blood pressure has been in the 140s, which may indicate hypotension, particularly given the patient's history of vasodilator therapy.
3. Infection: The patient's white blood cell count is elevated, which may indicate an infection. The patient's blood cultures and other laboratory results should be closely monitored for signs of infection.
4. Cardiac complications: The patient's troponin-T level is elevated, which may indicate cardiac damage or injury. The patient's electrocardiogram (ECG) and cardiac enzymes should be closely monitored for signs of cardiac complications.
5. Renal failure: The patient's creatinine level is elevated, which may indicate renal failure. The patient's urine output and electrolyte levels should be closely monitored for signs of renal failure.
6. Bleeding complications: The patient's platelet count is low, which may increase the risk of bleeding complications. The patient's bleeding time and clotting studies should be closely monitored for signs of bleeding complications."
177278.0,245895,2145-01-16 07:56:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, plavix 75mg daily
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30, give another unit now
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 160s range in the AM on [**1-15**].
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued last night.  Patient received 2u pRBC overnight with
   hct improvement from 22.7 to 27.1
   - continue nitro gtt
   - continue ASA 325mg daily, atorvastatin 80mg daily, plavix 75mg daily
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   - f/u TTE today
   - f/u Dr. [**Last Name (STitle) **] recs on high risk PCI to distal LMCA with TandemHeart
   assistance, either today or on Monday
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed.
   - transfusion goal hct 30, give another unit now
   - pm hct
   - started on PO famotidine
   .
   #. Pump: Patient appears euvolemic on exam.  Minimal basilar crackles,
   no evidence of R sided failure.  Patient was diursed at OSH.  Echo at
   OSH shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning
   prosthetic aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient
   with III/VI SEM at RUSB, with Carotid upstroke delay.
   - f/u TTE today
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 160s range in the AM on [**1-15**].
   - increase Metoprolol Tartrate from 37.5 mg Q6H to 50mg Q6h
   - start hydralazine 25-50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, here is a summary of the patient's health status and potential medical complications:

**Summary:**

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD). She was admitted to the ICU with unstable angina and underwent transfusion of 1 unit of packed red blood cells (pRBC) to achieve a hemoglobin (Hb) level of 30. She has been managed with nitroglycerin, heparin, clopidogrel, and aspirin. Her Hb level improved from 22.7 to 27.1 after transfusion. She has patent right internal mammary artery (RIMA) and right coronary artery (RCA), which may be providing collateral flow to her left anterior descending (LAD) artery.

**Potential Medical Complications:**

1. **Lower Gastrointestinal Bleed (LGIB):** The patient has a history of colonoscopy with no significant abnormalities, but the current bleeding is unclear. The patient's hemoglobin level dropped from 34 to 22.7, and she has basilar crackles on exam.
2. **Heart Failure:** The patient's ejection fraction (EF) is 60-65%, and she has moderate left ventricular hypertrophy (LVH) and moderate left atrial enlargement (LAE). Her pulmonary capillary wedge pressure (PCWP) is elevated, indicating increased left ventricular filling pressures.
3. **Renal Complications:** The patient has stage III-IV chronic kidney disease (CKD) and has a creatinine level of 1.6. She has multiple bilateral renal lesions on computed tomography (CT) abd/pelvis, which may require further evaluation.
4. **Hypertension:** The patient's systolic blood pressure (SBP) has been in the 160s range, which may indicate uncontrolled hypertension.
5. **Gastroesophageal Reflux Disease (GERD):** The patient has a history of GERD and is currently taking proton pump inhibitors (PPIs).
6. **Pulmonary Embolism (PE):** The patient has a history of peripheral vascular disease (PVD) and is at risk for PE.
7. **Ventricular Arrhythmias:** The patient's electrocardiogram (ECG) shows sinus rhythm, but she may be at risk for ventricular arrhythmias due to her underlying cardiac conditions.

**Recommendations:**

1. Continue nitroglycerin and heparin therapy.
2. Increase metoprolol tartrate to 50mg Q6h to control blood pressure.
3. Start hydralazine 25-50mg TID to control blood pressure.
4. Continue aspirin, clopidogrel, and atorvastatin.
5. Monitor the patient's hemoglobin level and transfuse as needed to maintain a goal Hb level of 30.
6. Consider further evaluation of the patient's renal lesions and potential underlying kidney disease.
7. Monitor the patient's blood pressure and adjust therapy as needed to control hypertension.
8. Continue to monitor the patient's cardiac status and adjust therapy as needed to control arrhythmias.
9. Consider further evaluation of the patient's gastrointestinal bleeding and potential underlying gastrointestinal disease."
177278.0,245895,2145-01-16 07:56:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Gen: NAD. Oriented x3. Loquacious, speaking comfortably in full
   sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of [**5-24**] cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Clear to auscultation throughout
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: Trace L lower extremity edema, Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with mild
   symmetric LVH with normal global and regional biventricular systolic
   function. Aortic valve bioprosthesis with thickened leaflets and
   abnormally-elevated gradients. Mild calcific mitral stenosis. Moderate
   to severe mitral regurgitation. Moderate tricuspid regurgitation.
   Moderate pulmonary hypertension.
   - continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - continue Metoprolol Tartrate from 50mg mg Q6H
   - continue Hydralazine 50mg TID
   - Procedure Monday, vascular surgery aware
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Hydralazine 50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition: Cardiac diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   - Transfused 1u for goal 30, with lasix [**12-19**] way through to avoid
   overload, post-transfusion Hct 30.3
   - Started Hydral 25mg PO TID & increased Lopressor to 50 qid for
   improved bp control, increased Hydral to 50mg PO TID & sbp's in the
   140's
   - weaned off nitro gtt with sbp's in the 130's
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Famotidine (Pepcid) - [**2145-1-15**] 08:00 AM
   Furosemide (Lasix) - [**2145-1-15**] 10:59 AM
   Heparin Sodium (Prophylaxis) - [**2145-1-15**] 11:45 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-16**] 07:55 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37.2
C (99
   Tcurrent: 36.7
C (98
   HR: 59 (59 - 81) bpm
   BP: 140/43(67) {108/43(60) - 170/77(99)} mmHg
   RR: 17 (10 - 23) insp/min
   SpO2: 95%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                  2,448 mL
                                                                    240 mL
   PO:
                                                                    620 mL
                                                                    240 mL
   TF:
   IVF:
                                                                    975 mL
   Blood products:
                                                                    854 mL
   Total out:
                                                                  3,150 mL
                                                                    430 mL
   Urine:
                                                                  3,150 mL
                                                                    430 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -702 mL
                                                                   -190 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 95%
   ABG: ///29/
   Physical Examination
   Gen: NAD. Oriented x3. Loquacious, speaking comfortably in full
   sentences.
   HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink.
   Neck: Supple with JVP of [**5-24**] cm.
   CV: Nondisplaced PMI.  RR, normal S1, S2. 3/6 SEM radiating to
   carotids.
   Chest: Clear to auscultation throughout
   Abd: Soft, NTND. No HSM or tenderness.
   Ext: Trace L lower extremity edema, Warm and well perfused. 2+ DP/ 1+PT
   pulses bilaterally.
   Labs / Radiology
   216 K/uL
   11.3 g/dL
   96 mg/dL
   1.6 mg/dL
   29 mEq/L
   3.8 mEq/L
   33 mg/dL
   99 mEq/L
   138 mEq/L
   33.0 %
   7.0 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
   WBC
   6.9
   7.3
   7.0
   Hct
   22.7
   27.1
   30.3
   33.0
   Plt
   [**Telephone/Fax (3) 12943**]
   Cr
   1.5
   1.6
   1.6
   TropT
   0.28
   Glucose
   237
   104
   96
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with mild
   symmetric LVH with normal global and regional biventricular systolic
   function. Aortic valve bioprosthesis with thickened leaflets and
   abnormally-elevated gradients. Mild calcific mitral stenosis. Moderate
   to severe mitral regurgitation. Moderate tricuspid regurgitation.
   Moderate pulmonary hypertension.
   - continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - continue Metoprolol Tartrate from 50mg mg Q6H
   - continue Hydralazine 50mg TID
   - Procedure Monday, vascular surgery aware
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Hydralazine 50mg TID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - continue to monitor
   - avoid renal toxins
   - renally dose meds
   - outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums prn
   - PO Famotidine
   ICU Care
   Nutrition: Cardiac diet
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD), who was admitted to the hospital with unstable angina. She underwent cardiac catheterization and was found to have 98% distal left main disease, 90% proximal/mid/distal right coronary artery (RCA) stenosis, and patent RCA-to-distal RCA collaterals. Due to her peripheral vascular disease, she is at high risk for percutaneous coronary intervention (PCI) and intra-aortic balloon pump (IABP) therapy.

The patient's current medications include aspirin, clopidogrel, heparin, and metoprolol tartrate, which have been adjusted to manage her unstable angina. She has also received 2 units of packed red blood cells (pRBC) due to anemia.

The patient's laboratory results show mild anemia, with a hemoglobin (Hb) level of 11.3 g/dL, and a hematocrit (Hct) level of 30.3%. Her creatinine level is 1.6 mg/dL, indicating stage III-IV chronic kidney disease (CKD).

The patient's physical examination is significant for a nondisplaced pulse in the mid-pectoral region, with a normal systolic blood pressure (SBP) and diastolic blood pressure (DBP) of 140/43 mmHg. Her electrocardiogram (ECG) shows a sinus rhythm, with a heart rate of 59 beats per minute (bpm).

Potential Medical Complications:

1. Gastrointestinal bleeding (GIB): The patient's history of GIB, along with her recent bleeding from the rectal examination, and her current bleeding risk factors, such as her anticoagulant therapy and her history of peptic ulcer disease, make her at high risk for recurrent GIB.
2. Lower gastrointestinal bleeding (LGIB): The patient's recent rectal bleeding and her history of colonoscopy with polyps suggest that she may be at risk for LGIB.
3. Chronic kidney disease (CKD) progression: The patient's current creatinine level of 1.6 mg/dL and her history of CKD stage III-IV make her at high risk for CKD progression.
4. Cardiovascular complications: The patient's history of AS and CAD, along with her current medication regimen, make her at high risk for cardiovascular complications, such as heart failure, arrhythmias, and acute coronary syndrome.
5. Respiratory complications: The patient's history of pulmonary hypertension and her current oxygen therapy make her at high risk for respiratory complications, such as acute respiratory distress syndrome (ARDS) and pneumonia.
6. Infection: The patient's history of GIB and her current bleeding risk factors make her at high risk for infection, such as sepsis and septic shock.
7. Nutritional deficiencies: The patient's history of CKD and her current medication regimen may lead to nutritional deficiencies, such as protein-energy malnutrition and vitamin deficiencies."
177278.0,245895,2145-01-17 07:07:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   FOR ON CALL INTERN ON SUNDAY: PLEASE PAGE VASCULAR SURGERY INTERN WITH
   TIME FOR PROCEDURE AS VSURG WILL BE ASSISTING
   [**1-16**]
   - Hydral to QID from TID
   - written for tylenol and codeine for sciatica-
   - had feeling of food sticking in esophagus, wrote for maalox, pain
   disappeared
   - got anxious and responded to 0.5 mg ativan
   - had family meeting, explained procedure (as best I could) and went
   over risks/benefits
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-17**] 07:06 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 59 (59 - 75) bpm
   BP: 136/45(67) {121/44(63) - 185/79(118)} mmHg
   RR: 21 (13 - 22) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                                                                    200 mL
   PO:
                                                                    840 mL
                                                                    200 mL
   TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,780 mL
                                                                    300 mL
   Urine:
                                                                  1,780 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -940 mL
                                                                   -100 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (Murmur: Systolic), Quit S1, Loud S2, 3/6 SEM to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   242 K/uL
   12.5 g/dL
   86 mg/dL
   1.4 mg/dL
   26 mEq/L
   3.9 mEq/L
   31 mg/dL
   100 mEq/L
   138 mEq/L
   37.3 %
   7.9 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   Plt
   [**Telephone/Fax (3) 12958**]42
   Cr
   1.5
   1.6
   1.6
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware, double check today
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   ------ Protected Section ------
   Attending
s Note:09.00hrs
   Reviewed overnight Examined Pt events .
   and agree with plan of Rx outlined by Dr.[**Last Name (STitle) **]
   [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 6658**]
   Spent 35 mins on case
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Name (NI) 6658**]
   on:[**2145-1-17**] 09:39 ------
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   FOR ON CALL INTERN ON SUNDAY: PLEASE PAGE VASCULAR SURGERY INTERN WITH
   TIME FOR PROCEDURE AS VSURG WILL BE ASSISTING
   [**1-16**]
   - Hydral to QID from TID
   - written for tylenol and codeine for sciatica-
   - had feeling of food sticking in esophagus, wrote for maalox, pain
   disappeared
   - got anxious and responded to 0.5 mg ativan
   - had family meeting, explained procedure (as best I could) and went
   over risks/benefits
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-17**] 07:06 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 59 (59 - 75) bpm
   BP: 136/45(67) {121/44(63) - 185/79(118)} mmHg
   RR: 21 (13 - 22) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                                                                    200 mL
   PO:
                                                                    840 mL
                                                                    200 mL
   TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,780 mL
                                                                    300 mL
   Urine:
                                                                  1,780 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -940 mL
                                                                   -100 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (Murmur: Systolic), Quit S1, Loud S2, 3/6 SEM to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   242 K/uL
   12.5 g/dL
   86 mg/dL
   1.4 mg/dL
   26 mEq/L
   3.9 mEq/L
   31 mg/dL
   100 mEq/L
   138 mEq/L
   37.3 %
   7.9 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   Plt
   [**Telephone/Fax (3) 12958**]42
   Cr
   1.5
   1.6
   1.6
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware, double check today
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
   ------ Protected Section ------
   Attending
s Note:09.00hrs
   Reviewed overnight Examined Pt events .
   and agree with plan of Rx outlined by Dr.[**Last Name (STitle) **]
   [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 6658**]
   Spent 35 mins on case
   ------ Protected Section Addendum Entered By:[**Name (NI) **] [**Name (NI) 6658**]
   on:[**2145-1-17**] 09:39 ------<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD) who was admitted to the intensive care unit (ICU) for unstable angina. She has undergone cardiac catheterization and has been medically managed with nitroglycerin, heparin, clopidogrel, and aspirin. The patient has a high risk of percutaneous coronary intervention (PCI) due to her 98% distal left main disease. She has also been diagnosed with possible lower gastrointestinal bleed (GIB) and is at risk for gastrointestinal bleeding due to her anticoagulant therapy.

The patient's vital signs are stable, with a temperature of 36.6C, heart rate of 59 beats per minute, and blood pressure of 136/45 mmHg. She has a SpO2 of 96% and is receiving oxygen therapy. Her respiratory support includes a non-invasive positive pressure ventilation (NIPPV) mask.

The patient's physical examination reveals a well-nourished individual with a soft, non-tender abdomen and normal bowel sounds. Her peripheral vascular disease is evident, with absent right and left distal pulses. Her neurologic examination is not assessed.

Laboratory results show anemia with a hemoglobin level of 12.5 g/dL and a hematocrit of 22.7%. Her white blood cell count is 6.9 K/uL, and her platelet count is 42 K/uL. Her creatinine level is 1.6 mg/dL, and her estimated glomerular filtration rate (eGFR) is stage III-IV.

Based on the patient's condition, I identify potential medical complications that may arise, including:

1. Gastrointestinal bleeding: The patient's anticoagulant therapy and history of GIB put her at risk for further bleeding.
2. Renal insufficiency: The patient's creatinine level is elevated, and her eGFR is stage III-IV, indicating chronic kidney disease.
3. Cardiovascular instability: The patient's unstable angina and history of CAD make her susceptible to cardiac events, including arrhythmias and myocardial infarction.
4. Pulmonary complications: The patient's history of pulmonary hypertension and moderate tricuspid regurgitation increase her risk for respiratory complications.
5. Neurologic complications: The patient's peripheral vascular disease and history of stroke increase her risk for neurologic complications, including cerebral edema and infarction.
6. Infection: The patient's immunocompromised state and history of colonoscopy increase her risk for infection, including sepsis and pneumonia.

To mitigate these risks, the patient should receive close monitoring and management of her anticoagulant therapy, cardiovascular status, and respiratory function. She should also receive prophylaxis for gastrointestinal bleeding and renal insufficiency."
177278.0,245895,2145-01-17 07:07:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   FOR ON CALL INTERN ON SUNDAY: PLEASE PAGE VASCULAR SURGERY INTERN WITH
   TIME FOR PROCEDURE AS VSURG WILL BE ASSISTING
   [**1-16**]
   - Hydral to QID from TID
   - written for tylenol and codeine for sciatica-
   - had feeling of food sticking in esophagus, wrote for maalox, pain
   disappeared
   - got anxious and responded to 0.5 mg ativan
   - had family meeting, explained procedure (as best I could) and went
   over risks/benefits
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-17**] 07:06 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 59 (59 - 75) bpm
   BP: 136/45(67) {121/44(63) - 185/79(118)} mmHg
   RR: 21 (13 - 22) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                                                                    200 mL
   PO:
                                                                    840 mL
                                                                    200 mL
   TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,780 mL
                                                                    300 mL
   Urine:
                                                                  1,780 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -940 mL
                                                                   -100 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (Murmur: Systolic), Quit S1, Loud S2, 3/6 SEM to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   242 K/uL
   12.5 g/dL
   86 mg/dL
   1.4 mg/dL
   26 mEq/L
   3.9 mEq/L
   31 mg/dL
   100 mEq/L
   138 mEq/L
   37.3 %
   7.9 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   Plt
   [**Telephone/Fax (3) 12958**]42
   Cr
   1.5
   1.6
   1.6
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware, double check today
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   FOR ON CALL INTERN ON SUNDAY: PLEASE PAGE VASCULAR SURGERY INTERN WITH
   TIME FOR PROCEDURE AS VSURG WILL BE ASSISTING
   [**1-16**]
   - Hydral to QID from TID
   - written for tylenol and codeine for sciatica-
   - had feeling of food sticking in esophagus, wrote for maalox, pain
   disappeared
   - got anxious and responded to 0.5 mg ativan
   - had family meeting, explained procedure (as best I could) and went
   over risks/benefits
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-17**] 07:06 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 59 (59 - 75) bpm
   BP: 136/45(67) {121/44(63) - 185/79(118)} mmHg
   RR: 21 (13 - 22) insp/min
   SpO2: 96%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
                  Total In:
                                                                    840 mL
                                                                    200 mL
   PO:
                                                                    840 mL
                                                                    200 mL
   TF:
   IVF:
   Blood products:
   Total out:
                                                                  1,780 mL
                                                                    300 mL
   Urine:
                                                                  1,780 mL
                                                                    300 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -940 mL
                                                                   -100 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 96%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (Murmur: Systolic), Quit S1, Loud S2, 3/6 SEM to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   242 K/uL
   12.5 g/dL
   86 mg/dL
   1.4 mg/dL
   26 mEq/L
   3.9 mEq/L
   31 mg/dL
   100 mEq/L
   138 mEq/L
   37.3 %
   7.9 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   Plt
   [**Telephone/Fax (3) 12958**]42
   Cr
   1.5
   1.6
   1.6
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   Other labs: PT / PTT / INR:12.0/25.7/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.7
   mg/dL, Mg++:2.7 mg/dL, PO4:2.4 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   - Procedure Monday, vascular surgery aware, double check today
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   overnight, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable at 33.0 this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   18 Gauge - [**2145-1-14**] 09:24 PM
   20 Gauge - [**2145-1-14**] 09:25 PM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD). She was transferred from another hospital with 98% left main disease and is at high risk for percutaneous coronary intervention (PCI) due to her peripheral vascular disease.

The patient has been medically managed for her unstable angina with nitroglycerin, heparin, clopidogrel, and aspirin. However, heparin was discontinued due to her active gastrointestinal bleed (GIB). The patient has been experiencing symptoms of food sticking in her esophagus, which has been managed with maalox. She has also been experiencing anxiety, which has been treated with 0.5 mg of ativan.

The patient's vital signs are stable, with a heart rate of 59-75 beats per minute, blood pressure of 136/45-185/79 mmHg, and oxygen saturation of 96%. Her respiratory status is also stable, with a respiratory rate of 21 breaths per minute.

The patient's laboratory results show a white blood cell count of 6.9-7.9 K/uL, hemoglobin of 22.7-34.6 g/dL, and platelet count of 42-129 K/uL. Her creatinine level has increased from 1.39-1.82 mg/dL, indicating stage III-IV chronic kidney disease (CKD).

The patient has multiple medical conditions, including AS, CAD, CKD, and peripheral vascular disease (PVD). She is at high risk for complications, including PCI, gastrointestinal bleeding, and renal failure.

Potential medical complications that can arise include:

1. Gastrointestinal bleeding: The patient's active GIB and discontinuation of heparin may increase her risk of bleeding complications.
2. Renal failure: The patient's stage III-IV CKD and increasing creatinine level may increase her risk of acute kidney injury or chronic kidney disease progression.
3. Cardiovascular complications: The patient's AS and CAD may increase her risk of cardiac events, including myocardial infarction, cardiac arrest, or cardiogenic shock.
4. Peripheral vascular complications: The patient's PVD may increase her risk of peripheral artery disease, gangrene, or limb loss.
5. Respiratory complications: The patient's stable respiratory status may change if she develops respiratory failure or pneumonia.
6. Neurological complications: The patient's stable neurological status may change if she develops neurological deficits or seizures.

To manage these potential complications, the patient should be closely monitored and treated according to her medical conditions."
177278.0,245895,2145-01-18 07:37:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 83F hx AS, CAD s/p 1v [**Hospital 12969**] transferred from OSH with
   98% LM dz
   24 Hour Events:
   Plan for high-risk PCI today of LM dz
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-18**] 07:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 59 (59 - 88) bpm
   BP: 143/49(74) {125/45(58) - 163/93(97)} mmHg
   RR: 17 (13 - 21) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
             Total In:
                                                                    500 mL
                                                                    511 mL
   PO:
                                                                    500 mL
                                                                    100 mL
   TF:
   IVF:
   411 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    350 mL
   Urine:
                                                                    900 mL
                                                                    350 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -400 mL
                                                                    161 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), (Murmur: Systolic), III/VI to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   259 K/uL
   11.9 g/dL
   93 mg/dL
   1.4 mg/dL
   26 mEq/L
   4.1 mEq/L
   34 mg/dL
   103 mEq/L
   140 mEq/L
   35.7 %
   7.6 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
                             [**2145-1-18**]  05:25 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   7.6
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   35.7
   Plt
   [**Telephone/Fax (3) 12958**]42
   259
   Cr
   1.5
   1.6
   1.6
   1.4
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   93
   Other labs: PT / PTT / INR:11.9/26.3/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.3
   mg/dL, Mg++:2.7 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - High risk PCI today - cardiac and vascular surgery aware
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   yesterday, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2145-1-18**] 07:00 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 83F hx AS, CAD s/p 1v [**Hospital 12969**] transferred from OSH with
   98% LM dz
   24 Hour Events:
   Plan for high-risk PCI today of LM dz
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-18**] 07:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 59 (59 - 88) bpm
   BP: 143/49(74) {125/45(58) - 163/93(97)} mmHg
   RR: 17 (13 - 21) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
             Total In:
                                                                    500 mL
                                                                    511 mL
   PO:
                                                                    500 mL
                                                                    100 mL
   TF:
   IVF:
   411 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    350 mL
   Urine:
                                                                    900 mL
                                                                    350 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -400 mL
                                                                    161 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), (Murmur: Systolic), III/VI to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   259 K/uL
   11.9 g/dL
   93 mg/dL
   1.4 mg/dL
   26 mEq/L
   4.1 mEq/L
   34 mg/dL
   103 mEq/L
   140 mEq/L
   35.7 %
   7.6 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
                             [**2145-1-18**]  05:25 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   7.6
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   35.7
   Plt
   [**Telephone/Fax (3) 12958**]42
   259
   Cr
   1.5
   1.6
   1.6
   1.4
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   93
   Other labs: PT / PTT / INR:11.9/26.3/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.3
   mg/dL, Mg++:2.7 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - High risk PCI today - cardiac and vascular surgery aware
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   yesterday, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable this AM.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2145-1-18**] 07:00 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD) who was transferred to the ICU from another hospital due to unstable angina and 98% left main disease. She has been medically managed with nitroglycerin, heparin, clopidogrel, and aspirin, but her unstable angina has been refractory to medical management. The patient has a high risk of cardiac and vascular complications, including a possible lower gastrointestinal bleed.

The patient's vital signs are stable, with a heart rate of 59 beats per minute, blood pressure of 143/49 mmHg, and oxygen saturation of 97%. Her physical examination is notable for a systolic murmur and peripheral vascular disease. Laboratory results show a hemoglobin level of 11.9 g/dL, white blood cell count of 6.9 K/uL, and creatinine level of 1.6 mg/dL.

The patient is at high risk for complications, including cardiac arrest, arrhythmias, and bleeding. She has a history of gastrointestinal bleeding and is at risk for further bleeding due to her anticoagulation therapy. The patient's creatinine level is elevated, and she has bilateral renal lesions on CT scan.

Potential medical complications:

1. Cardiac arrest: The patient's high-risk PCI procedure today increases her risk of cardiac arrest.
2. Arrhythmias: The patient's history of atrial fibrillation and her current sinus bradycardia increase her risk of arrhythmias.
3. Bleeding: The patient's history of gastrointestinal bleeding and her anticoagulation therapy increase her risk of further bleeding.
4. Renal failure: The patient's elevated creatinine level and bilateral renal lesions on CT scan increase her risk of renal failure.
5. Infection: The patient's indwelling catheters and recent hospitalization increase her risk of infection.
6. Respiratory failure: The patient's chronic obstructive pulmonary disease (COPD) and her recent hospitalization increase her risk of respiratory failure.
7. Septic shock: The patient's history of gastrointestinal bleeding and her recent hospitalization increase her risk of septic shock.

Recommendations:

1. Monitor the patient's vital signs closely, including her heart rate, blood pressure, and oxygen saturation.
2. Continue to manage the patient's pain and anxiety with medications as needed.
3. Monitor the patient's bleeding risk and adjust her anticoagulation therapy accordingly.
4. Continue to monitor the patient's renal function and adjust her medications as needed.
5. Consider consulting with a nephrologist for further management of the patient's renal disease.
6. Consider consulting with a cardiologist for further management of the patient's cardiac disease.
7. Continue to monitor the patient's respiratory status and adjust her oxygen therapy as needed.
8. Consider consulting with an infectious disease specialist for further management of the patient's risk of infection."
177278.0,245895,2145-01-18 07:37:00,Physician ,Physician Resident Progress Note,"Chief Complaint: 83F hx AS, CAD s/p 1v [**Hospital 12969**] transferred from OSH with
   98% LM dz
   24 Hour Events:
   Plan for high-risk PCI today of LM dz with tandem heart
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-18**] 07:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 59 (59 - 88) bpm
   BP: 143/49(74) {125/45(58) - 163/93(97)} mmHg
   RR: 17 (13 - 21) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
             Total In:
                                                                    500 mL
                                                                    511 mL
   PO:
                                                                    500 mL
                                                                    100 mL
   TF:
   IVF:
   411 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    350 mL
   Urine:
                                                                    900 mL
                                                                    350 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -400 mL
                                                                    161 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), (Murmur: Systolic), III/VI to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   259 K/uL
   11.9 g/dL
   93 mg/dL
   1.4 mg/dL
   26 mEq/L
   4.1 mEq/L
   34 mg/dL
   103 mEq/L
   140 mEq/L
   35.7 %
   7.6 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
                             [**2145-1-18**]  05:25 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   7.6
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   35.7
   Plt
   [**Telephone/Fax (3) 12958**]42
   259
   Cr
   1.5
   1.6
   1.6
   1.4
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   93
   Other labs: PT / PTT / INR:11.9/26.3/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.3
   mg/dL, Mg++:2.7 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - High risk PCI today with tandem heart - cardiac and vascular surgery
   aware
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
 will wean as tolerated
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   yesterday, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable this AM. Will continue to follow.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted. Currently at
   baseline.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2145-1-18**] 07:00 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: 83F hx AS, CAD s/p 1v [**Hospital 12969**] transferred from OSH with
   98% LM dz
   24 Hour Events:
   Plan for high-risk PCI today of LM dz with tandem heart
   Allergies:
   Sulfa (Sulfonamide Antibiotics)
   Unknown;
   Vasotec (Oral) (Enalapril Maleate)
   cough;
   Pletal (Oral) (Cilostazol)
   Unknown;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2145-1-18**] 07:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since [**46**] AM
   Tmax: 37
C (98.6
   Tcurrent: 36.9
C (98.4
   HR: 59 (59 - 88) bpm
   BP: 143/49(74) {125/45(58) - 163/93(97)} mmHg
   RR: 17 (13 - 21) insp/min
   SpO2: 97%
   Heart rhythm: SB (Sinus Bradycardia)
   Wgt (current): 70 kg (admission): 70.2 kg
   Height: 67 Inch
             Total In:
                                                                    500 mL
                                                                    511 mL
   PO:
                                                                    500 mL
                                                                    100 mL
   TF:
   IVF:
   411 mL
   Blood products:
   Total out:
                                                                    900 mL
                                                                    350 mL
   Urine:
                                                                    900 mL
                                                                    350 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                   -400 mL
                                                                    161 mL
   Respiratory support
   O2 Delivery Device: None
   SpO2: 97%
   ABG: ///26/
   Physical Examination
   General Appearance: Well nourished, No acute distress
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Loud), (Murmur: Systolic), III/VI to
   carotids
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Absent), (Left DP pulse: Absent)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Resonant : ),
   (Breath Sounds: Clear : )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right lower extremity edema: Absent, Left lower extremity
   edema: Absent
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   259 K/uL
   11.9 g/dL
   93 mg/dL
   1.4 mg/dL
   26 mEq/L
   4.1 mEq/L
   34 mg/dL
   103 mEq/L
   140 mEq/L
   35.7 %
   7.6 K/uL
        [image002.jpg]
                             [**2145-1-14**]  09:54 PM
                             [**2145-1-15**]  05:16 AM
                             [**2145-1-15**]  05:00 PM
                             [**2145-1-16**]  05:03 AM
                             [**2145-1-16**]  09:10 PM
                             [**2145-1-17**]  04:44 AM
                             [**2145-1-18**]  05:25 AM
   WBC
   6.9
   7.3
   7.0
   7.9
   7.6
   Hct
   22.7
   27.1
   30.3
   33.0
   34.6
   37.3
   35.7
   Plt
   [**Telephone/Fax (3) 12958**]42
   259
   Cr
   1.5
   1.6
   1.6
   1.4
   1.4
   TropT
   0.28
   Glucose
   237
   104
   96
   86
   93
   Other labs: PT / PTT / INR:11.9/26.3/1.0, CK / CKMB /
   Troponin-T:24//0.28, Alk Phos / T Bili:/1.1, LDH:178 IU/L, Ca++:8.3
   mg/dL, Mg++:2.7 mg/dL, PO4:2.0 mg/dL
   Assessment and Plan
   Patient is a 83 yo fm with hx of AS, CAD s/p 1V [**Hospital 8408**] transfered from
   OSH with 98% left main disease.
   .
   #. CAD: Stable on medical managment.  OSH Cath shows showed 98%
   discrete distal left main disease, 90% proximal/mid/distal RCA, patent
   RIMA-distal RCA, 85% mid right external iliac stenosis.  Patient is at
   very high risk for PCI with 98% distal left main disease. The patient
   is a poor substrate for IABP given her peripheral vascular disease.
   Has patent RIMA-RCA that is likely providing collateral flow to her
   LAD.  Patient's unstable angina has been medically managed on Nitro
   gtt, Heparin, Clopidogrel, ASA.  Given patient
s active GIB, heparin
   was discontinued on [**1-14**]. Nitro gtt weaned on [**1-16**]. Patient received 2u
   pRBC on admission, with stable Hct. TTE showed EF>55% with LVH with
   normal global and regional systolic function. Aortic valve
   bioprosthesis with thickened leaflets and abnormally-elevated
   gradients. Mild calcific mitral stenosis. Moderate to severe mitral
   regurgitation. Moderate tricuspid regurgitation. Moderate pulmonary
   hypertension. We are observing the ICU prior to her high risk procedure
   - High risk PCI today with tandem heart - cardiac and vascular surgery
   aware
   - Continue ASA 325mg daily, Atorvastatin 80mg daily, Plavix 75mg daily
   - Continue Metoprolol Tartrate from 50mg mg Q6H
   - Increase Hydralazine 50mg frequency to QID
 will wean as tolerated
   .
   #.  Possible Lower GI bleed:  HCT at OSH 34 on admission, dropped to 28
   on transfer and 22.7 last night at [**Hospital1 19**].  Patient with BRBPR on Rectal
   Examination, no bloody bowel movement.  Heparin was discontinued last
   night in the setting of GIB.  This is less likely UGIB given no bump in
   BUN.  Patient reported having colonoscopy 5 years ago with no
   significant abnormalities except for some polyps, was told that she did
   not have to come back for 10 years.  Patient received 2u pRBC
   yesterday, with hct bump from 22.7 to 27.1.  CT abd/pelvis ruled out RP
   bleed. Hct stable this AM. Will continue to follow.
   - Daily CBC
   - PO Famotidine
   .
   #. Pump: Patient appears euvolemic on exam with no evidence of fluid
   overload or R sided failure.  Patient was diuresed at OSH.  Echo at OSH
   shows EF 60-65%, mod LVH, mod LAE, mild [**Last Name (un) **], nl functioning prosthetic
   aortic valve, mod/sev MR, mild/mod TR, mild PR.  Patient with III/VI
   SEM at RUSB, with Carotid upstroke delay.
   - no diuresis today, with goal I/O even
   .
   #. Rhythm: NSR
   - continue to monitor on telemetry
   .
   #. HTN:  Patient
s sBP has been in the 130s since increasing
   antihypertensive regimen & discontinuing Nitro gtt.
   - Metoprolol Tartrate from 50 mg Q6H
   - Increase Hydralazine 50mg frequency to QID
   .
   # CKD: stage III-IV.  Creatinine on [**2144-10-9**] was 1.82, prior to that,
   her Creatinine was 1.39 and 1.48 in [**2142**].  Creatinine 1.6 today.  CT
   abd/pelvis showed Multiple well-circumscribed bilateral renal lesions,
   correlation with prior imaging or a renal US is warranted. Currently at
   baseline.
   - Continue to monitor
   - Avoid renal toxins
   - Renally dose meds
   - Outpatient renal US
   .
   #. PVD:
   - hold Pentoxifylline 400mg TID for now
   .
   # GERD:
   - Tums or maalox prn
   - PO Famotidine
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2145-1-18**] 07:00 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: H2 blocker
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 83-year-old female with a history of aortic stenosis (AS) and coronary artery disease (CAD), who has undergone previous cardiac catheterization and has been transferred to the ICU for high-risk PCI with tandem heart.

The patient's current vital signs include:

* Temperature: 98.4F (37C)
* Heart rate: 59 beats per minute (bpm)
* Blood pressure: 143/49 mmHg
* Respiratory rate: 17 breaths per minute (bpm)
* Oxygen saturation: 97%
* Heart rhythm: Sinus bradycardia

The patient's physical examination reveals:

* General appearance: Well-nourished, no acute distress
* Cardiovascular: Normal S1 and S2 heart sounds, with a loud S2 and a systolic murmur of 3/6 intensity
* Respiratory/chest: Symmetric expansion, resonant percussion, and clear breath sounds
* Abdominal: Soft, non-tender, and with bowel sounds present
* Extremities: No evidence of edema in either lower extremity
* Skin: Not assessed
* Neurologic: Not assessed

Laboratory results include:

* Hemoglobin: 11.9 g/dL
* Hematocrit: 35.7%
* White blood cell count: 7.6 K/uL
* Platelet count: 259 K/uL
* Creatinine: 1.6 mg/dL
* Troponin-T: 0.28 ng/mL
* Glucose: 93 mg/dL
* Other lab results: Normal or within normal limits

The patient has several medical conditions, including:

* Coronary artery disease with 98% distal left main disease
* Aortic stenosis with a bioprosthetic valve
* Mild calcific mitral stenosis
* Moderate to severe mitral regurgitation
* Moderate tricuspid regurgitation
* Moderate pulmonary hypertension
* Chronic kidney disease (CKD) stage III-IV
* Peripheral vascular disease (PVD)

The patient's plan includes:

* High-risk PCI with tandem heart today
* Continue ASA 325mg daily, Atorvastatin 80mg daily, and Plavix 75mg daily
* Continue Metoprolol Tartrate 50mg every 6 hours
* Increase Hydralazine 50mg frequency to QID
* Monitor for possible lower gastrointestinal bleed
* Continue daily CBC and PO Famotidine
* Monitor for fluid overload and adjust diuretic therapy as needed
* Continue to monitor renal function and avoid renal toxins

Potential medical complications that may arise include:

* Hemorrhage from the gastrointestinal tract or kidneys
* Acute kidney injury or worsening of chronic kidney disease
* Cardiac tamponade or other cardiac complications
* Pulmonary edema or other respiratory complications
* Infection or sepsis
* Bleeding or other complications related to the PCI procedure

It is essential to closely monitor the patient's condition and adjust treatment accordingly to prevent or manage these potential complications."
